Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.2874
-0.0145 (-4.80%)
Mar 11, 2026, 11:28 AM EDT - Market open
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $7.78 million as of March 11, 2026. Its market cap has decreased by -49.71% in one year.
Market Cap
7.78M
Enterprise Value
5.68M
1-Year Change
-49.71%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $7.78M, a decrease of -96.05%. That is a compound annual growth rate of -47.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 8.18M | -13.18% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | 197.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 8.29M |
| Bolt Biotherapeutics | 8.25M |
| PharmaCyte Biotech | 8.08M |
| Alaunos Therapeutics | 8.06M |
| KALA BIO | 7.86M |
| Alzamend Neuro | 7.53M |
| Addex Therapeutics | 7.49M |
| GridAI Technologies | 7.40M |